Comparing various off-the-shelf methods for bone tissue engineering in a large-animal ectopic implantation model: Bone marrow, allogeneic bone marrow stromal cells, and platelet gel

Tissue Engineering - Part A.

Volumn 14, Issue 8, 2008, Pages 1435-1443

  Geuze, Ruth E ^a   Kruyt, Moyo C ^a   Verbout, Abraham J ^a   Alblas, Jacqueline ^a   Dhert, Wouter J A ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; BLOOD SUBSTITUTES; CALCIUM; CALCIUM PHOSPHATE; CELLS; COLLOIDS; CYTOLOGY; ENGINEERING RESEARCH; GELATION; GELS; GRAFTS; HEALTH; PEPTIDES; PLASMAS; PLATELETS; SCAFFOLDS; TECHNOLOGY; TISSUE ENGINEERING;

ALLOGENEIC BONE MARROW; BIPHASIC CALCIUM PHOSPHATES; BONE FORMATION; BONE GRAFTING; BONE MARROW; BONE TISSUE ENGINEERING; BONE TISSUES; FLUOROCHROME; FLUOROCHROMES; GROWTH FACTORS; OFF-THE-SHELF COMPONENTS; PARASPINAL MUSCLES; PLATELET GELS; REGENERATIVE MEDICINES; SEEDED CELLS; TRANSFORMING GROWTH FACTOR;

BONE;

CALCIUM PHOSPHATE; FLUORESCENT DYE; FLUOROCHROME; TRANSFORMING GROWTH FACTOR BETA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ARTICLE; BONE MARROW; BONE TISSUE; FEMALE; GEL; HYBRID; IMPLANTATION; NONHUMAN; OSSIFICATION; PLASMA; PRIORITY JOURNAL; STROMA CELL; THROMBOCYTE; TISSUE ENGINEERING;

ANIMALIA; CAPRA HIRCUS;

EID: 48749129182     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2007.0210     Document Type: Article

References (50)

1. Vaccaro, A.R., Chiba, K., Heller, J.G., Patel, T., Thalgott, J.S., Truumees, E., Fischgrund, J.S., Craig, M.R., Berta, S.C., and Wang, J.C. Bone grafting alternatives in spinal surgery. Spine J 2, 206, 2002.
2. Damien, C.J. and Parsons, J.R. Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater 2, 187, 1991.
3. Lane, J.M., Tomin, E., and Bostrom, M.P. Biosynthetic bone grafting. Clin Orthop Relat Res S107, 1999.
4. Cornell, C.N. and Lane, J.M. Current understanding of osteo-conduction in bone regeneration. Clin Orthop Relat Res S267, 1998.
5. Vaccaro, A.R. The role of the osteoconductive scaffold in synthetic bone graft. Orthopedics 25, S571, 2002.
6. Urist, M.R. Bone: formation by autoinduction. Science 150, 893, 1965.
7. Yaszemski, M.J., Payne, R.G., Hayes, W.C., Langer, R., and Mikos, A.G. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 17, 175, 1996.
8. Arrington, E.D., Smith, W.J., Chambers, H.G., Bucknell, A.L., and Davino, N.A. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 300, 1996.
9. Banwart, J.C., Asher, M.A., and Hassanein, R.S. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 20, 1055, 1995.
10. Sandhu, H.S., Grewal, H.S., and Parvataneni, H. Bone grafting for spinal fusion. Orthop Clin North Am 30, 685, 1999.
11. Friedenstein, A.J., Latzinik, N.W., Grosheva, A.G., and Gorskaya, U.F. Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured cells in porous sponges. Exp Hematol 10, 217, 1982.
12. Bruder, S.P., Kraus, K.H., Goldberg, V.M., and Kadiyala, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80, 985, 1998.
13. Petite, H., Viateau, V., Bensaid, W., Meunier, A., De Pollak, C., Bourguignon, M., Oudina, K., Sedel, L., and Guillemin, G. Tissue-engineered bone regeneration. Nat Biotechnol 18, 959, 2000.
14. Tse, W.T., Pendleton, J.D., Beyer, W.M., Egalka, M.C., and Guinan, E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389, 2003.
15. Aggarwal, S. and Pittenger, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815, 2005.
16. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., Mcintosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., and Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30, 42, 2002.
17. Arinzeh, T.L., Peter, S.J., Archambault, M.P., Van Den Bos, C., Gordon, S., Kraus, K., Smith, A., and Kadiyala, S. Allogeneic mesenchymal stem cells regenerate bone in a criticalsized canine segmental defect. J Bone Joint Surg Am 85-A, 1927, 2003.
18. Koc, O.N., Gerson, S.L., Cooper, B.W., Dyhouse, S.M., Haynesworth, S.E., Caplan, A.I., and Lazarus, H.M. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18, 307, 2000.
19. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., and Ringden, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439, 2004.
20. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P.D., Matteucci, P., Grisanti, S., and Gianni, A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838, 2002.
21. Meisel, R., Zibert, A., Laryea, M., Gobel, U., Daubener, W., and Dilloo, D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103, 4619, 2004.
22. Whang, K., Tsai, D.C., Nam, E.K., Aitken, M., Sprague, S.M., Patel, P.K., and Healy, K.E. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J Biomed Mater Res 42, 491, 1998.
23. Hasharoni, A., Zilberman, Y., Turgeman, G., Helm, G.A., Liebergall, M., and Gazit, D. Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2. J Neurosurg Spine 3, 47, 2005.
24. Seeherman, H.J., Azari, K., Bidic, S., Rogers, L., Li, X.J., Hollinger, J.O., and Wozney, J.M. rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. J Bone Joint Surg Am 88, 1553, 2006.
25. Govender, S., Csimma, C., Genant, H.K., Valentin-Opran, A., Amit, Y., Arbel, R., Aro, H., Atar, D., Bishay, M., Borner, M.G., Chiron, P., Choong, P., Cinats, J., Courtenay, B., Feibel, R., Geulette, B., Gravel, C., Haas, N., Raschke, M., Hammacher, E., Van Der Velde, D., Hardy, P., Holt, M., Josten, C., Ketterl, R.L., Lindeque, B., Lob, G., Mathevon, H., Mccoy, G., Marsh, D., Miller, R., Munting, E., Oevre, S., Nordsletten, L., Patel, A., Pohl, A., Rennie, W., Reynders, P., Rommens, P.M., Rondia, J., Rossouw, W.C., Daneel, P.J., Ruff, S., Ruter, A., Santavirta, S., Schildhauer, T.A., Gekle, C., Schnettler, R., Segal, D., Seiler, H., Snowdowne, R.B., Stapert, J., Taglang, G., Verdonk, R., Vogels, L., Weckbach, A., Wentzensen, A., and Wisniewski, T. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am, 84-A, 2123, 2002.
26. Friedlaender, G.E., Perry, C.R., Cole, J.D., Cook, S.D., Cierny, G., Muschler, G.F., Zych, G.A., Calhoun, J.H., Laforte, A.J., and Yin, S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A Suppl 1, S151, 2001.
27. Ross, R., Raines, E.W., and Bowen-Pope, D.F. The biology of platelet-derived growth factor. Cell 46, 155, 1986.
28. Nakamura, T., Hanada, K., Tamura, M., Shibanushi, T., Nigi, H., Tagawa, M., Fukumoto, S., and Matsumoto, T. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136, 1276, 1995.
29. Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E., and Georgeff, K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85, 638, 1998.
30. Friedenstein, A.J., Chailakhyan, R.K., and Gerasimov, U.V. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20, 263, 1987.
31. Kruyt, M.C., De Bruijn, J.D., Yuan, H., van Blitterswijk, C.A., Verbout, A.J., Oner, F.C., and Dhert, W.J. Optimization of bone tissue engineering in goats: a peroperative seeding method using cryopreserved cells and localized bone formation in calcium phosphate scaffolds. Transplantation 77, 359, 2004.
32. Yuan, H., Van Den Doel, M., Li, S., van Blitterswijk, C.A., De Groot, K., and De Bruijn, J.D. A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats. J Mater Sci Mater Med 13, 1271, 2002.
33. Kruyt, M.C., Dhert, W.J., Yuan, H., Wilson, C.E., van Blitterswijk, C.A., Verbout, A.J., and De Bruijn, J.D. Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat. J Orthop Res 22, 544, 2004.
34. Savarino, L., Cenni, E., Tarabusi, C., Dallari, D., Stagni, C., Cenacchi, A., Fornasari, P.M., Giunti, A., and Baldini, N. Evaluation of bone healing enhancement by lyophilized bone grafts supplemented with platelet gel: a standardized methodology in patients with tibial osteotomy for genu varus. J Biomed Mater Res B Appl Biomater 76, 364, 2006.
35. Kitoh, H., Kitakoji, T., Tsuchiya, H., Mitsuyama, H., Nakamura, H., Katoh, M., and Ishiguro, N. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis - a preliminary result of three cases. Bone 35, 892, 2004.
36. Thor, A., Franke-Stenport, V., Johansson, C.B., and Rasmusson, L. Early bone formation in human bone grafts treated with platelet-rich plasma: preliminary histomorphometric results. Int J Oral Maxillofac Surg 36, 11642007.
37. Thor, A., Wannfors, K., Sennerby, L., and Rasmusson, L. Reconstruction of the severely resorbed maxilla with autogenous bone, platelet-rich plasma, and implants: 1-year results of a controlled prospective 5-year study. Clin Implant Dent Relat Res 7, 209, 2005.
38. Butterfield, K.J., Bennett, J., Gronowicz, G., and Adams, D. Effect of platelet-rich plasma with autogenous bone graft for maxillary sinus augmentation in a rabbit model. J Oral Maxillofac Surg 63, 370, 2005.
39. Gerard, D., Carlson, E.R., Gotcher, J.E., and Jacobs, M. Effects of platelet-rich plasma on the healing of autologous bone grafted mandibular defects in dogs. J Oral Maxillofac Surg 64, 443, 2006.
40. Celotti, F., Colciago, A., Negri-Cesi, P., Pravettoni, A., Zaninetti, R., and Sacchi, M.C. Effect of platelet-rich plasma on migration and proliferation of SaOS-2 osteoblasts: role of platelet-derived growth factor and transforming growth factor-beta. Wound Repair Regen 14, 195, 2006.
41. Weibrich, G., Kleis, W.K., and Hafner, G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants 17, 184, 2002.
42. Arpornmaeklong, P., Kochel, M., Depprich, R., Kubler, N.R., and Wurzler, K.K. Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study. Int J Oral Maxillofac Surg 33, 60, 2004.
43. Wilson, C.E., Kruyt, M.C., De Bruijn, J.D., van Blitterswijk, C.A., Oner, F.C., Verbout, A.J., and Dhert, W.J. A new in vivo screening model for posterior spinal bone formation: comparison of ten calcium phosphate ceramic material treatments. Biomaterials 27, 302, 2006.
44. Nash, T.J., Howlett, C.R., Martin, C., Steele, J., Johnson, K.A., and Hicklin, D.J. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 15, 203, 1994.
45. Warnke, P.H., Springer, I.N., Wiltfang, J., Acil, Y., Eufinger, H., Wehmoller, M., Russo, P.A., Bolte, H., Sherry, E., Behrens, E., and Terheyden, H. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 364, 766, 2004.
46. Warnke, P.H., Springer, I.N., Acil, Y., Julga, G., Wiltfang, J., Ludwig,K., Russo, P.A., Sherry, E., Sivananthan, S., Hedderich, J., and Terheyden, H. The mechanical integrity of in vivo engineered heterotopic bone. Biomaterials 27, 1081, 2006.
47. Cancedda, R., Giannoni, P., and Mastrogiacomo, M. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 28, 4240, 2007.
48. Reikeras, O., Shegarfi, H., Wang, J.E., and Utvag, S.E. Lipopolysaccharide impairs fracture healing: an experimental study in rats. Acta Orthop 76, 749, 2005.
49. Kruyt, M.C., de Bruijn, J.D., Oner, F.C., van Blitterswijk, C.A., Verbout, A.J., and Dhert, W.J.A. Analysis of the dynamics of bone formation, effect of cell seeding density, and potential of allogenic cells in cell-based bone tissue engineering in goats. Tissue Eng 14, 2008.
50. Everts, P. Autologous platelet growth factor gel facilitates bone substitute and autogenous bone growth in a goat model. Abstract. Eur Surg Res 39, 10, 2007.